BioELife Corp. (LITH)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Aug 22, 2025
BioELife Market Cap
BioELife has a market cap or net worth of $941.00 as of September 12, 2025. Its market cap has decreased by -80.00% in one year.
Market Cap
941.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 7, 2009, BioELife's market cap has decreased from 813.97K to 941.00, a decrease of -99.88%. That is a compound annual growth rate of -34.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 941.00 | - |
| Dec 31, 2024 | 941.00 | 10,355.56% |
| Dec 19, 2023 | 9.00 | -99.52% |
| Dec 30, 2022 | 1.88K | - |
| Dec 31, 2021 | 1.88K | -99.85% |
| Dec 31, 2020 | 1.22M | -7.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |